Support For Senate Bill On Generic Biotechnology Drugs Might Be Deteriorating
Jul 24th 2007Drug InformationPharma Industry
CongressDaily on Thursday examined how the “fragile support” for a Senate bill (S 1695) that would allow FDA to approve generic versions of biotechnology drugs is “deteriorating at the same time House lawmakers are trying to persuade leaders not to allow for such a provision in an FDA bill” (Edney, CongressDaily, 7/19). [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
